Log In
Print this Print this

Cannabinor (formerly PRS-211,375)

  Manage Alerts
Collapse Summary General Information
Company Pharmos Corp.
DescriptionCannabinoid CB2 receptor (CNR2) agonist
Molecular Target Cannabinoid CB2 receptor (CNR2)
Mechanism of ActionCannabinoid CB2 receptor agonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today